Released May 14, 2012, after the close
10-Q filed May 14, 2012, 44 days after period end · 0001193125-12-231316
Q1 2012 · 10-Q
Revenue$2.75M$2.75M no prior Q1 2011 on fileno prior Q4 2011 on file
Net Income-$10.54M-$10.54M N/M vs Q1 2011N/M vs Q4 2011
EPS Diluted-$0.52-$0.52 N/M vs Q1 2011no prior Q4 2011 on file
Gross Profit$2,357,000—
Operating Cash Flow-$4,885,000N/M
Margins · derived
Gross margin85.7%
Net margin-383.2%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $2.75M | — |
| Net Income | -$10.54M | -$3.84M |
| EPS Diluted | -$0.52 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR